Literature DB >> 29145186

The Klüver-Bucy Syndrome.

Douglas J Lanska1.   

Abstract

In 1937, Heinrich Klüver and Paul Bucy described a dramatic behavioral syndrome in monkeys after bilateral temporal lobectomy. The full Klüver-Bucy syndrome (KBS) - hyperorality, placidity, hypermetamorphosis, dietary changes, altered sexual behavior, and visual agnosia - is evident within 3 weeks following operation. Some KBS features (i.e., hyperorality, placidity, hypermetamorphosis) persist indefinitely, whereas others gradually resolve over several years. Klüver and Bucy were initially unaware of an earlier report of KBS by Sanger Brown and Edward Schäfer in 1888. Human cases were recognized in the 1950s, as surgeons employed bilateral temporal lobectomies to treat seizures. Various attempts were made to localize the component features to specific areas of the temporal lobe, with mixed success. Bilateral ventral temporal ablations and bilateral temporal lobectomies produced marked impairment in visual discrimination, whereas lateral resections or unilateral lesions did not. Discrete bilateral lesions of the lateral amygdaloid nucleus produced a permanent "hypersexed state." By the 1970s, it was clear that the major symptoms of KBS are produced by destroying either the temporal neocortex or the amygdala bilaterally. KBS is now thought to be caused by disturbances of temporal portions of limbic networks that interface with multiple cortical and subcortical circuits to modulate emotional behavior and affect. The clinical features of KBS in man are similar to those in monkeys, but the full syndrome is rarely seen, probably because the anterior temporal lobe dysfunction is usually less severe than that following total temporal lobe ablation in monkeys. Human KBS does not occur in isolation, but is typically part of a complex behavioral syndrome that almost always includes amnesia and aphasia, and that may also include dementia and seizures. The treatment of KBS is difficult and often unsatisfactory.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 29145186     DOI: 10.1159/000475721

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN: 0300-5186


  7 in total

Review 1.  Prediction errors and valence: From single units to multidimensional encoding in the amygdala.

Authors:  Adam T Brockett; Daniela Vázquez; Matthew R Roesch
Journal:  Behav Brain Res       Date:  2021-02-14       Impact factor: 3.332

Review 2.  Incentive motivation: 'wanting' roles of central amygdala circuitry.

Authors:  Shelley M Warlow; Kent C Berridge
Journal:  Behav Brain Res       Date:  2021-05-20       Impact factor: 3.332

Review 3.  Neuronal Plasticity in the Amygdala Following Predator Stress Exposure.

Authors:  Rupshi Mitra
Journal:  Front Behav Neurosci       Date:  2019-02-20       Impact factor: 3.558

4.  A case report of persistent risky dietary behaviors in a bipolar disorder patient.

Authors:  Yanping Duan; Jinya Cao; Paul Summergrad; Jing Wei
Journal:  BMC Psychiatry       Date:  2019-11-08       Impact factor: 3.630

Review 5.  Neuroanatomy and function of human sexual behavior: A neglected or unknown issue?

Authors:  Rocco S Calabrò; Alberto Cacciola; Daniele Bruschetta; Demetrio Milardi; Fabrizio Quattrini; Francesca Sciarrone; Gianluca la Rosa; Placido Bramanti; Giuseppe Anastasi
Journal:  Brain Behav       Date:  2019-09-30       Impact factor: 2.708

Review 6.  Structural and Functional Alterations of the Temporal lobe in Schizophrenia: A Literature Review.

Authors:  Arveen Kaur; Deepak M Basavanagowda; Bindu Rathod; Nupur Mishra; Sehrish Fuad; Sadia Nosher; Zaid A Alrashid; Devyani Mohan; Stacey E Heindl
Journal:  Cureus       Date:  2020-10-26

7.  Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors.

Authors:  Ashley E Tate; Hanna Sahlin; Shengxin Liu; Yi Lu; Sebastian Lundström; Henrik Larsson; Paul Lichtenstein; Ralf Kuja-Halkola
Journal:  Mol Psychiatry       Date:  2022-03-18       Impact factor: 13.437

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.